entertainment -WSS

entertainment

author：explore 2025-09-30 20:46:54 - browse：3

Christine Kao/STAT

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies.

PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves. So when new market developments threaten to diminish or wipe away that revenue stream, PBMs find crafty ways to keep as much of those dollars as possible — often at the expense of employers.

One such case occurred last year, when a wave of Humira biosimilars entered the market and drug companies slashed the list prices of their insulin products. CVS Caremark, the PBM owned by CVS Health that oversees the prescription drug benefits of 103 million people, told its employer clients that it anticipated “more lower-cost products (including specialty biosimilars) may become preferred products” on its lists of approved drugs for 2024, according to documents obtained by STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： STAT Madness 2024: Meet the contenders

focus

WSS

Body of missing toddler recovered in Delaware River days after flood: Police

Children’s Hospital revives plan for pedestrian bridge

Caitlin Bernard's story shows physicians can't shy from advocacy

As Taiwan prepares for anti

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Artificial intelligence advances fuel industry trying to preserve loved ones after death

explore

entertainment

hotspot

Sports medicine is finally prioritizing gender equality

Pfizer is about to make a big push in cancer. Will investors listen?

Hollywood unions extend contract negotiations for actors

Review: 'Barbie' will hit you like a shot in the heart

Jerome Adams on the need for new antivirals for Covid

Review: 'Barbie' will hit you like a shot in the heart

Apple is now the first public company to be valued at $3 trillion

STAT Madness 2024: Meet the contenders

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Will.i.am, Britney Spears release new single, 'Mind Your Business'

focus

CDC advisory group OKs chikungunya vaccine

Readout Newsletter: Beam, Prozac, "TechBio" and more

Study fuels hope CAR

In new study, freeze

Russian special forces kill a gunman who broke into a private house near Moscow

Change Healthcare cyberattack shows risk of industry consolidation

focus

focus

focus

hotspot